TIBBS: 2022 Translational Medicine Symposium
The 2022 Translational Medicine Symposium is co-sponsored by the Program in Translational Medicine and the Cancer Cell Biology Training Program.
The symposium will feature two keynote addresses, talks by trainees in both programs, and a career panel of program alumni.
Symposium Agenda
9:00-10:00 a.m. | Opening Keynote Address
10:15-11:45 a.m. | Student presentations in 4 concurrent rooms
12:00-1:00 p.m. | Lunch with keynote speakers
1:15-2:00 p.m. | Alumni career panel
2:15-3:45 p.m. | Student presentations in 4 concurrent rooms
4:00-5:00 p.m. | Closing Keynote Address and awards
About the Keynote Speakers:
Navdeep Chadel, PhD
Navdeep S. Chandel, PhD is the David W. Cugell, MD, Professor of Medicine, Biochemistry and Molecular Genetics at Northwestern University Feinberg School of Medicine. Chandel’s work has demonstrated that mitochondrial metabolism is a potential target for cancer therapy.
Karen Corbin, PhD, RD
Corbin is a Faculty Investigator at the Translational Research Institute for Metabolism and Diabetes. Her program of research focuses on nutrition, enterohepatic metabolism and the mechanisms that drive individual susceptibility to metabolic diseases. Corbin is also CEO of the science communication company Geeks that Speak. After 20 years of traversing the worlds of healthcare and science, she realized that a fundamental barrier exists for translating ideas into solutions. Geeks that Speak exists to inspire and empower scientists to become impactful storytellers.